ClinicalTrials.gg
Drug

Ciclesonide clinical trials

Also written Alvesco, BI 54903 and Omnaris.

studies test it
65
open now
1
in phase 3
43
first study started
2000

How each study uses ciclesonide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ciclesonide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Oct 2006 · OMNARIS · NDA 022004 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ciclesonide
44
Ciclesonide (XRP1526)
3
Ciclesonide Nasal Spray
2
BI 54903 MD
2

Brand

Alvesco
6
Omnaris
4

Development codes

BI 54903
6

Studies by the year they started

65 studies that test it; most in 2005 (10)

Studies that test ciclesonide, by start year
YearStudies
20001
20011
20021
20037
20049
200510
20069
20072
20083
20091
20103
201110
20141
20161
20205
20251

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
12
Phase 3
43
Phase 4
8
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 54 · Other 11

AstraZeneca (35) · Boehringer Ingelheim (8) · Sanofi (4) · Sumitomo Pharma America, Inc. (3) · Covis Pharma S.à.r.l. (2) · University Hospital, Bordeaux (1) · Korea University Guro Hospital (1) · Cantonal Hosptal, Baselland (1)

Often tested with

Tested in the same studies.

Telmisartan (1) · Fluticasone (1) · Azelastine (1) · Tiotropium (1) · Montelukast (1) · Formoterol (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test ciclesonide.

Studies

Open first, then newest update. How each study uses ciclesonide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 65

See all 65 studies that test ciclesonide →

Given beside what is tested · 3 — ciclesonide is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with ciclesonide

Codes

What other systems call ciclesonide · ClinicalTrials.gg INT004169

  • MeSH (NLM) C120481ciclesonideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) S59502J185CICLESONIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 274964Confirmed FDA, Wikidata
  • Wikidata Q5119448ciclesonideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65326CiclesonideOne source FDA
  • DrugBank DB01410One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.